COVID-19 News- Ciclesonide - Nsp3 - Nsp4 Mutations Feb 01, 2023 5 days ago
COVID-19 News: Researchers from the Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Murayama Branch, Tokyo-Japan have in a new study discovered that the usage of the inhaled asthma drug ciclesonide is causing frequent occurrences of SARS-CoV-2 NSp3 And Nsp4 Mutations!
Thailand Medical News had in our previous COVID-19 News coverages s...
COVID-19 Drugs - Fluvoxamine Causes Heart Valve Disease Jan 28, 2023 8 days ago
COVID-19 Drugs: Researchers from Columbia University’s Department of Surgery in collaboration with the Pediatric Heart Valve Center at Children’s Hospital of Philadelphia (CHOP), the University of Pennsylvania, and the Valley Hospital Heart Institute have discovered that serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition known as degenerat...
COVID-19 Drugs - N-Acetylcysteine or NAC Jan 12, 2023 25 days ago
COVID-19 Drugs: A new study by Italian researchers have found that NAC or N-Acetylcysteine is not only an effective antiviral agent against all of the SARS-CoV-2 variants but also has immunomodulatory properties that can help prevent disease severity.
Thailand Medical News had as early as April 2020 written about the benefits of taking NAC or N-Acetylcysteine supplements to help prevent C...
COVID-19 Drugs - Molnupiravir Dec 24, 2022 1 month ago
COVID-19 Drugs: A new study led by researchers from University of Oxford has found that Molnupiravir that is being promoted by many charlatans and dubious health experts and authorities, does not reduce hospitalization or risk of mortality in vaccinated adults who have contracted COVID-19!
In fact, the overpriced drug that costs more than US$720 for a seven-day course day course has been ...
COVID-19 News - Chlorpromazine Dec 17, 2022 2 months ago
COVID-19 News: A new study by researchers from Inserm (French National Institute of Health and Medical Research) has validated that cholesterol and ceramide lipids facilitate SARS-CoV-2 spike protein-mediated membrane fusion.
The researchers also found that Chlorpromazine (CPZ), a commonly used antipsychotic drug, could be used to inhibit this fusion and also prevent SARS-CoV-2 cellular e...
COVID-19 Drugs - Ursodeoxycholic Acid Dec 15, 2022 2 months ago
COVID-19 Drugs: A new breakthrough study led by researchers from Cambridge University-UK has found that the commonly available cheap generic drug used to treat a type of liver disease ie Ursodeoxycholic Acid (UDCA), could be repurposed to not only treat COVID-19 but also act as an effective prophylactic.
The drug is also not only effective against all existing SARS-CoV-2 variants but also...
Source: COVID-19 Drugs - Diabetics - SGLT-2 Inhibitors Dec 08, 2022 2 months ago
COVID-19 Drugs: A new study by researchers from Fujian Medical University -China, Fujian Provincial Hospital-China and Fujian Academy of Medical Sciences-China has found that diabetics taking SGLT-2i drugs like canagliflozin, dapagliflozin, and empagliflozin prior to contracting COVID-19 have reduced adverse outcomes.
SGLT2i or sodium-glucose cotransporter-2 inhibitors are a class of prescription...
COVID-19 News - Bebtelovimab Dec 01, 2022 2 months ago
COVID-19 News: The U.S. FDA issued an announcement in the last 24 hours stating that Bebtelovimab is not currently authorized in any U.S. region to treat COVID-19.
According to the announcement, the predominant variants in circulation that includes the BQ.1 and BQ.1.1 variants ad sub-lineages can no longer be neutralized by the monoclonal antibody drug Bebtelovimab that is made by ph...
COVID-19 News - Molnupiravir Nov 30, 2022 2 months ago
COVID-19 News: When Thailand Medical News in September 2021 warned about the dangers of the US FDA approved drug Molnupiravir to treat COVID-19, our news coverage was not taken seriously as most Westerners always think that only the media in their own countries that is funded by crooked politicians, unethical billionaires, greedy pharma giants and those controlling the COVID-19 narratives are the ...
COVID-19 News - Interferon Lambda Nov 19, 2022 3 months ago
COVID-19 News: A new breakthrough study by Canadian researchers from the University of Manitoba, University of Toronto, Canada University Health Network and University of Alberta, Edmonton has found that treating SARS-CoV-2 infected individuals with interferon Lambda helps in rapid clearance of the virus even in those with age-related delays in the induction of T cell immunity!
This new t...
Source: COVID-19 News - Inhalable Sodium Bicarbonate As An Adjuvant For COVID-19 Nov 19, 2022 3 months ago
COVID-19 News: A randomized clinical trial conducted by researchers from the Faculty of Medicine, Mansoura University - Egypt has found that inhalable sodium bicarbonate could be used as adjuvant in COVID-19 prophylactic and treatment protocols!
Most COVID-19 News outlets have not been covering on the various clinical trials involving cheaper repurposed drugs or compounds that can be used...
Source: COVID-19 Drugs - Metformin Nov 18, 2022 3 months ago
COVID-19 Drugs: Study findings from yet another research led by scientists from the University of Minnesota Medical School has added to the growing evidence that metformin, a common and cheap generic diabetic drug is able to decrease the risk of COVID-19 severity.
Thailand Medical News had previously covered on various past studies that showed metformin not only reduced the risk of COVID-...
Source: COVID-19 News - Cyclodextrins - SARS-CoV-2 - Antivirals Nov 17, 2022 3 months ago
COVID-19 News: A new study by researchers from Spain led by scientist from the Cell Structure Lab, Centro Nacional de Biotecnologia, CNB - CSIC, Campus de Cantoblanco, Madrid -Spain has found that cheap natural cyclodextrins especially Beta Cyclodextrins can be used as antivirals against SARS-CoV-2!
Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of...
Source: COVID-19 Drugs - Fluvoxamine Nov 07, 2022 3 months ago
COVID-19 Drugs: A new study by researchers from Intermountain Medical Center; Stanford, Salt Lake City-Utah, USA has confirmed that the usage of selective serotonin reuptake inhibitors (SSRIs) such as Fluoxetine or Fluvoxamine does not reduce COVID Severity.
Shockingly, the study findings showed that hospitalization and death were significantly greater in the those taking SSRIs such as Fluoxetine...
Source: COVID-19 Drugs - Memantine - NMT5 Nov 02, 2022 3 months ago
COVID-19 Drugs: Researchers from Scripps Research Institute - California-USA have created a variant of the generic drug Memantine which is an Aminoadamantane compound, to inhibit the SARS-CoV-2 virus entry by targeting the ACE2 receptors.
Prevention of infection and propagation of the SARS-CoV-2 coronavirus is a high priority in the ongoing COVID-19 pandemic which is expected to get worse...
Source; COVID-19 Drugs -Inhaled Ciclesonide Oct 30, 2022 3 months ago
COVID-19 Drugs: A new study by researchers from the Division of Pulmonary and Critical Care Medicine at MacKay Memorial Hospital- Taiwan has found that the usage of inhaled Ciclesonide reduces risk of mortality and need for mechanical ventilation in hospitalized COVID-19 patients.
Thailand Medical News had already reported as early as August 2020 about the possible prophylactic and also t...
Source: COVID-19 News - Banana Lectin H84T As A SARS-CoV-2 Antiviral Oct 21, 2022 4 months ago
COVID-19 News: A new study conducted by researchers from University of Hong Kong – China, Johannes Kepler University Linz, Linz – Austria and the University of Michigan, Ann Arbor-USA has found that lectins derived from bananas could serve as effective antivirals against the SARS-CoV-2 virus including against the Omicron variant.
As early as 2020, Thailand Medical News has cov...
Source: COVID-19 Drugs - Paxlovid Oct 13, 2022 4 months ago
COVID-19 Drugs: Leading cardiologists and physicians from various hospitals and medical centers across the state of Massachusetts-USA have issued a warning of adverse drug interactions especially involving heart medications in COVID-19 patients treated with Paxlovid (Nirmatrelvir/Ritonavir).
The team of specialists from Lahey Hospital and Medical Center, Brigham and Women’s Hospital...
Source: COVID-19 Drugs -Glutamine, Pyruvate, Rosiglitazone, Arginine, 2-DG Oct 11, 2022 4 months ago
COVID-19 Drugs: A new breakthrough study by researchers from the Zhongnan Hospital of Wuhan University-China and Southern University of Science and Technology, Shenzhen-China has found that glutamine and pyruvate supplementation, and also the drug diabetic drug Rosiglitazone can reduce and prevent cytokine upregulation hyperinflammation as result of inflammation in macrophages induced by the SARS-...
Source: COVID-19 Drugs - Metformin Oct 11, 2022 4 months ago
COVID-19 Drugs: Spanish researchers and physicians have in a new study found that the diabetic drug Metformin (Glucophage) lowers the risk of disease severity and fatal outcomes in diabetic patients infected with the SARS-CoV-2 coronavirus.
The study involved medical researchers from the Hospital Clinic of Barcelona-Spain, Universitat Autònoma de Barcelona-Spain and Fundació Institu...
Source: COVID-19 Drugs - Evusheld - Bebtelovimab Oct 04, 2022 4 months ago
COVID-19 Drugs: Thailand Medical News has been warning since the last two weeks that we are entering a very dangerous phase of the COVID-19 pandemic, one in which not only are we are going to be faced with an onslaught of more than 30 to 50 circulating new Omicron sub-lineages that are more transmissible and immune evasive but also more pathogenic. Reinfections and Co-infections are going to be th...
Source: Medical News - Povidone Nasal Sprays For COVID-19 Aug 24, 2022 6 months ago
A study by researchers from Mahidol University, Siam University and Samut Sakhon Hospital has found that 0.4% povidone-iodine nasal spray is not the least effective as a prophylaxis to prevent SARS-CoV-2 infections.
During the initial phases of the SARS-CoV-2 pandemic, numerous Indian scammers and Indian run companies were promoting various Povidone-iodine nasal sprays products as prophyl...
Source: Medical News - COVID-19 Drugs - Metformin Aug 22, 2022 6 months ago
COVID-19 Drugs: A randomized clinical trial involving 1431 non-hospitalized patients showed that metformin reduced the risk of COVID-19 severity and risk of COVID-19 mortality.
The randomized double-blinded placebo- controlled trial by conducted by the COVID-OUT consortium that is led by researchers from University of Minnesota and also involved medical scientists from the UnitedHealth Gro...
Source: Medical News - COVID-19 Drugs -Remdesivir Aug 13, 2022 6 months ago
COVID-19 Drugs: A new study by Japanese researchers from Tohoku University, Kyushu University, Okayama University and the National Institutes of Natural Sciences, Okazaki-Japan has alarmingly found that the U.S. FDA approved and heavily promoted drug for COVID-19 ie Remdesivir activates the urotensin II receptor and induces cardiomyocyte dysfunction that can lead to heart issues that can also end ...
COVID-19 Drugs: The World Health Organization has strongly advised against the usage of two drugs to treat non-severe COVID-19, ie the antidepressant drug fluvoxamine and the gout drug colchicine.
The WHO said that both drugs were not recommended for patients with mild or moderate COVID-19 because there is currently insufficient evidence that they improve important outcomes for patients, and both...
COVID-19 Drugs: A new study by medical researchers from Stanford University-California has found that the commonly available and cheap generic drug, Spironolactone (Aldactone) improves clinical outcomes especially in severe COVID-19 infections.
Spironolactone, sold under the brand name Aldactone among others, is a medication that is primarily used to treat fluid build-up due to heart failure, liv...
Source: COVID-19 Drugs-Paxlovid Jun 16, 2022 8 months ago
In a surprising move, the American big pharma company that is a major supporter of the Biden administration…Pfizer Inc on Tuesday announced that it would halt enrollment in a clinical trial for its claimed COVID-19 antiviral COVID-19 drug-Paxlovid, in standard-risk patients after data analysis showed a non-significant reduction in hospitalizations and deaths.
Typically, the standar...
Source: COVID-19 Drugs - Nirmatrelvir & Paxlovid Jun 10, 2022 8 months ago
COVID-19 Drugs: A new study by researchers from the Copenhagen University Hospital-Denmark, the Department of Immunology and Microbiology at the University of Copenhagen-Denmark and the Technical University of Denmark has found that the mutations E166V and L50F+E166V that are found on various emerging SARS-CoV-2 variants, weakens nirmatrelvir-Mpro binding. Nirmatrelvir, an oral protease inhibitor ...
Source: COVID-19 Drugs - Clofoctol May 30, 2022 8 months ago
COVID-19 Drugs: A new study by researchers from the University of Lille-France, the Institut Pasteur de Lille-France, the Center for Infection and Immunity of Lille-France, CNRS, INSERM, and CHU Lille0France has found that the existing antibiotic Clofoctol could be repurposed to treat COVID-19.
Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nos...
Source: COVID-19 Drugs - Viagra - Sildenafil May 18, 2022 9 months ago
COVID-19 Drugs: A new study by researchers from the University College London-UK, Imperial College London and the Royal Brompton Hospital-UK has found that the drug Viagra can be used to treat COVID-19 related pneumonitis and moderate to severe ARDS.
Sildenafil, sold under the brand name Viagra among others, is a medication used to treat erectile dysfunction and pulmonary arterial hyperte...
COVID-19 Drugs: Researchers from the Indian Institute of Science, India has found that the asthma drug Montelukast (Singulair) can block the SARS-CoV-2 non-structural protein 1 (Nsp1,) which in turn results in the inhibition of SARS-CoV-2 replication, showing it prowess as potential COVID-19 drug!
Montelukast is a drug used in the maintenance treatment of asthma that is marketed under the trade n...
Source: SARS-CoV-2-Minocycline Apr 23, 2022 10 months ago
SARS-CoV-2-Minocycline: News has emerged that China is now using the antibiotic drug Minocycline to treat COVID-19 cases in various cities across China including Shanghai despite lack of published clinical trial studies showing its efficacy.
Chinese researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College along with scientists from the Inner Mongolia Medical Un...
We at Thailand Medical News think that urgent studies are needed by independent and credible researchers with regards to Pfizer’s Paxlovid as there are many now many unpublished case reports by both physicians and also patients reporting anomalies when the so-called antiviral drug is used to treat COVID-19 patients.
One common occurrence being reported is that many when tested posit...
Source: Medical News - NAC Apr 14, 2022 10 months ago
Yet another worrisome study finding has emerged that adds to the growing list of human host cellular and biological pathways… now numbering in hundreds, that are dysregulated or disrupted by the SARS-CoV-2 coronavirus with implications for long term medical and health issues, some that can end up with fatal outcomes.
Already Thailand Medical News has issued numerous warnings that m...
Source: Thailand Medical Apr 01, 2022 10 months ago
No this is not some April Day prank nor it is some fear porn to get everyone anxious, rather this is stark warning that everyone who has been exposed to the proteins of the SARS-CoV-2 virus through whichever means need to take it upon themselves to do frequent medical checkups and also to take necessary precautions and also to seek out treatment protocols to self-treat themselves as even the...
Source: COVID-19 Drugs - Aspirin Mar 25, 2022 11 months ago
COVID-19 Drugs: A new cohort study by researchers from George Washington University-USA has demonstrated that aspirin use is associated with reduced risk of mortality in hospitalized moderate COVID-19 patients.
Previous observational studies already showed that aspirin use may be associated with reduced mortality in high-risk hospitalized patients with COVID-19, but aspirin’s effica...
Source: COVID-19 Drugs - Famotidine Mar 02, 2022 11 months ago
COVID-19 Drugs: The study findings of a phase 2 clinical trial led by Feinstein Institutes for Medical Research-New York and Cold Spring Harbor Laboratory shows that the common heart burn drug Famotidine is effective in treating COVID-19 disease especially for those with in mild to moderate cases.
It should be noted that Thailand Medical News first reported on the potential of using famot...
Pharma News: Fake molnupiravir pills under a variety of brandnames are appearing not only on various illegal online sites that are selling controlled medications but also in many pharmacies around the world that are known to also sell controlled drugs illegally and also in the various notorious drug ‘black-market retail sites’.
It was reported that only after a week in January when mo...
Source: COVID-19 Drugs-Kasugamycin-FRG Jan 30, 2022 1 year ago
COVID-19 Drugs: Scientists from Brown University-Rhode Island have found that that Chitinase 3-Like-1 (CHI3L1) inhibitors stops replication of the SARS-CoV-2 coronavirus including the Omicron and Delta variants in the human host.
Chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, is a secreted glycoprotein that is approximately 40kDa in size that in humans is encoded by the CHI3L1 g...
Source: Calcium Channel Inhibitors-SARS-CoV-2 Jan 20, 2022 1 year ago
Calcium Channel Inhibitors-SARS-CoV-2: A new study by researchers from the Institute of Biophysics, Johannes Kepler University Linz-Austria has found that calcium channel inhibitors including existing drugs such as amlodipine, nifedipine, felodipine, verapamil and the phytochemical neferine from the lotus plants can possibly treat SARS-CoV-2 infections.
Strategies for inhibition of cellular ...
Source: SIRT5 Inhibitors As Potential COVID-19 Drugs Jan 11, 2022 1 year ago
A new study by researchers from Buck Institute for Research on Aging-California, Gladstone Institute-California, University of California-San Francisco and the QBI COVID-19 Research Group (QCRG)-California has revealed that the SARS-CoV-2 coronavirus can be inhibited and controlled by downregulating human host SIRT5. The study findings showed that SIRT5 is a proviral factor and that SARS-CoV-2 lev...
Source: COVID-19 Drugs - Ramatroban Jan 03, 2022 1 year ago
COVID-19 Drugs: A small clinical study conducted by researchers from the Charak Foundation-California-USA, Regulatory Wisdom-India, the EyeSight Eye Hospital and Retina Centre-India and the University of California Irvine-USA has found that the drug Ramatroban, which is a thromboxane A2 & prostaglandin D2 receptor antagonist can be used to treat COVID respiratory distress and hypoxem...
Source: COVID-19 Prophylactics-Therapeutics Dec 14, 2021 1 year ago
COVID-19 Prophylactics-Therapeutics: Scientist from Friedrich-Alexander University Erlangen-Nürnberg-Germany, Ulm University Medical Center-Germany, University Hospital Tübingen-Germany and Marinomed Biotech AG-Austria have in a new study found that the safe and non-toxic natural compound iota-carrageenan has the ability to inhibit replication of all existing SARS-CoV-2 variants of ...
Source: COVID-19 Drugs - Calcium Channel Blockers Dec 12, 2021 1 year ago
COVID-19 Drugs: A new study by researchers from Cornell University -New York has found that that entry of coronaviruses such as SARS-1, MERS and even SARS-CoV-2 is a Ca2+-dependent process. The study findings also propose that existing FDA approved calcium channel blockers could be repurposed as potential COVID-19 drugs.
We are making a special appeal to all readers to please help to sustain this...
COVID-19 Drugs: A new study by scientists from the University of Florida-USA and the University of Saskatchewan has found that the common over-the-counter antihistamine diphenhydramine when paired with the commonly available supplement lactoferrin, a protein found in cow and human milk, the pair had the capability to hinder the SARS-CoV-2 virus during tests in monkey cells and ...
SourceL COVID-19 Drugs - Molnupiravir Dec 05, 2021 1 year ago
COVID-19 Drugs: Updated data on molnupiravir shows the drug reduces hospitalization or death by 30%, down from the initially reported 50% efficacy.
Last week Merck has provided updated data on its COVID-19 antiviral, molnupiravir, that shows the antiviral to be significantly less effective against the virus than previously thought. https://www.merck.com/news/merck-and-ridgeback-biotherapeutics-p...
Source: COVID-19 Drug Scams-Favipiravir Nov 29, 2021 1 year ago
Since the beginning of the pandemic, certain countries like China and Japan were advocating the use of Favipravir (Avigan) to treat COVID-19 despite lack of evidence to show its efficacy. Surprisingly, although China was advocating its use to other countries by giving and selling stocks of the drug, it was never really endorsed in its own national guidelines for COVID-19 treatment neither was it u...
Source: COVID-19 Prophylactics-Therapeutics Nov 26, 2021 1 year ago
COVID-19 Prophylactics-Therapeutics: Researchers from the University of Tennessee Health Science Center-USA and Instituto de Ciencia y Tecnología-Argentina have in a new study demonstrated that a combination of iota-carrageenan and xylitol inhibit SARS-CoV-2 in Vero cell culture, paving the way for the development of a prophylactic and therapeutic nasal spray for COVID-19.
Since the...
COVID-19 Drugs: University of California-San Francisco and Stanford University researchers have in a new study involving the meta-analysis of health records from 87 health care centers across America found that individuals taking a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs), especially Fluoxetine or Fluvoxamine were significantly less likely to die of COVID-19 ...
Source: Medical News-COVID-19 Drugs Nov 14, 2021 1 year ago
COVID-19 Drugs: A new study by Austrian researchers from the Medical University of Vienna, Kaiser Franz Josef Hospital, University of Innsbruck and the Johannes Kepler University-Austria has found that not only does the anticoagulant-low molecular weight Heparin reduces the risk of disease severity and mortality about those with COVID019 but it also curtails the duration of the SARS-CoV-2 Infectio...
Source: COVID-19 Treatments - Hydrogen Nov 13, 2021 1 year ago
COVID-19 Treatments: Researchers from Tianjin Medical University General Hospital-China and Weifang Medical University-China are exploring the usage of hydrogen therapy as a possible adjuvant treatment for COVID-19.
COVID-19 is an acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has no specific and effective treatment to date except ...
COVID-19 Drugs: A new COVID-19 drug breakthrough study led by researchers from the Department of Infectious Diseases, Konkuk University-Gwangjin-gu-South Korea along with help from Chung-Ang University- Gyeonggi-South Korea has demonstrated that the pharmaceutical product called Hemin can be used to treat COVID-19 via heme oxygenase-1 Induction.
The antiviral effects of heme oxygenase-1 (HO-1), a...
Source: SARS-CoV-2 Antivirals Nov 08, 2021 1 year ago
SARS-CoV-2 Antivirals: Maybe as a result of an oversupply of Pacific oysters due to a trade spat with China, Australians are desperate to find alternative uses for their oysters or maybe there is some scientific basis after all since a study has been published in the peer reviewed journal: Reviews In Medical Virology, showing the possible benefits of hemoplymph from Pacific oysters (Crassostrea gi...
Fluvoxamine-COVID-19: The results from the TOGTHER clinical trial has shown that fluvoxamine reduces the risk of COVID-19 disease severity and reduces the need for hospitalization.
The TOGETHER trial is a randomized, adaptive platform trial to investigate the efficacy of repurposed treatments for COVID-19 disease among high-risk adult outpatients. The trial was designed and done in partner...
Source: Autophagy-SARS-CoV-2 Oct 26, 2021 1 year ago
Autophagy-SARS-CoV-2: A review published by a researcher, Dr Theo Rein from the Max Planck Institute of Psychiatry, Munich-Germany in the peer reviewed Journal of Cellular Biochemistry highlights the importance of autophagy in the fight against SARS-CoV-2 infections and also identifies potential drugs that could be repurposed to treat COVID-19. https://onlinelibrary.wiley.com/doi/10.1002/jcb.30166...
.jpg)
